Previous Close | 36.60 |
Open | 36.40 |
Bid | 36.00 x 0 |
Ask | 36.80 x 0 |
Day's Range | 36.20 - 36.40 |
52 Week Range | 25.80 - 46.00 |
Volume | |
Avg. Volume | 3 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | Aug 07, 2024 - Aug 12, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q1 2024 Earnings Call Transcript May 9, 2024 Xenon Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.61771, expectations were $-0.69. Xenon Pharmaceuticals Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing […]
Financial and Operational Highlights from the Latest Earnings Report
Xenon (XENE) reports better-than-expected first-quarter 2024 earnings. Its development programs for azetukalner in epilepsy and MDD are progressing well.